Noninvasive evaluation of flow reserve in the left anterior descending coronary artery in patients with cardiac syndrome X.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  American Journal of Cardiology

• Publication date

  2007-05-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/J.AMJCARD.2006.12.070PMID 17493464
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Löffler’s endomyocarditis

  2005cited by this paper
• The quantification of absolute myocardial perfusion in humans by contrast echocardiography: algorithm and validation.

  2005cited by this paper
• Cardiac syndrome X: a critical overview and future perspectives

  2005cited by this paper
• Usefulness of coronary flow reserve measured by transthoracic coronary Doppler ultrasound to detect severe left anterior descending coronary artery stenosis.

  2003cited by this paper
• Abnormal subendocardial perfusion in cardiac syndrome X detected by cardiovascular magnetic resonance imaging.

  2002cited by this paper
• New noninvasive method for coronary flow reserve assessment: contrast-enhanced transthoracic second harmonic echo Doppler.

  1999cited by this paper
• Quantification of myocardial blood flow with ultrasound-induced destruction of microbubbles administered as a constant venous infusion.

  1998cited by this paper
• Noninvasive assessment of significant left anterior descending coronary artery stenosis by coronary flow velocity reserve with transthoracic color Doppler echocardiography.

  1998cited by this paper
• Noninvasive assessment of coronary flow velocity and coronary flow velocity reserve in the left anterior descending coronary artery by Doppler echocardiography: comparison with invasive technique.

  1998cited by this paper
• Both endothelium-dependent and endothelium-independent function is impaired in patients with angina pectoris and normal coronary angiograms.

  1997cited by this paper
• Evidence of impaired endothelium-dependent coronary vasodilatation in patients with angina pectoris and normal coronary angiograms.

  1993cited by this paper
• Comparison of regional myocardial blood flow in syndrome X and one-vessel coronary artery disease.

  1993cited by this paper
• Reduced Coronary Dilatory Capacity and Ultrastructural Changes of the Myocardium in Patients with Angina Pectoris But Normal Coronary Arteriograms

  1981cited by this paper

• Relationship between serum mature brain-derived neurotrophic factor level and coronary slow flow phenomenon: a cross-sectional study

  2025influential citation
• Coronary Microvascular Dysfunction and Vasospastic Angina—Pathophysiology, Diagnosis and Management Strategies

  2025cites this paper
• Coronary vasospasm testing: escape from the cath lab!

  2024cites this paper
• 2023 Guidelines of the Taiwan Society of Cardiology on the Diagnosis and Management of Chronic Coronary Syndrome.

  2023cites this paper
• Contemporary Diagnosis and Management of Patients with MINOCA

  2023cites this paper
• Noninvasive evaluation of dynamic microvascular dysfunction in ischemia and no obstructive coronary artery disease patients with suspected vasospasm

  2023cites this paper
• Role of different echocardiographic modalities in the assessment of microvascular function in women with ischemia and no obstructive coronary arteries

  2022cites this paper
• Echocardiographic Assessment of Primary Microvascular Angina and Primary Coronary Microvascular Dysfunction.

  2022cites this paper
• Coronary microvascular dysfunction is common in patients hospitalized with COVID‐19 infection

  2022cites this paper
• Assessment and Treatment for Coronary Microvascular Dysfunction by Contrast Enhanced Ultrasound

  2022cites this paper
• Ischemia and no obstructive coronary arteries (INOCA): A narrative review.

  2022cites this paper
• A clinical trial for computed tomography myocardial perfusion based non-invasive index of microcirculatory resistance (MPBIMR): rationale and trial design.

  2022cites this paper
• Microvascular angina (Cardiac Syndrome X) from a historical overview, epidemiology, pathophysiology to treatment recommendations - a minireview.

  2021cites this paper
• 13 (2) January 2021 CVJ.pmd

  2021cites this paper
• Coronary microvascular disease: diagnostic evaluation

  2021cites this paper
• Clinical presentation and management of myocardial infarction with nonobstructive coronary arteries (MINOCA): A literature review

  2021cites this paper
• Ischemia and no obstructive coronary arteries in patients with stable ischemic heart disease.

  2021cites this paper
• Coronary microvascular dysfunction: an overview.

  2020cites this paper
• Evaluation of non-invasive imaging parameters in coronary microvascular disease: a systematic review

  2020cites this paper
• Impairment of coronary flow velocity reserve and global longitudinal strain in women with cardiac syndrome X and slow coronary flow.

  2020cites this paper
• Assessment and pathophysiology of microvascular disease: recent progress and clinical implications

  2020cites this paper
• Coronary Microvascular Dysfunction and the Role of Noninvasive Cardiovascular Imaging

  2020cites this paper
• Clinical outcomes in patients with primary stable microvascular angina: is the Jury still out?

  2019cites this paper
• Diagnostic Approach to Patients with Stable Angina and No Obstructive Coronary Arteries

  2019cites this paper
• Myocardial Small Vessel Disease and Endothelial Dysfunction

  2018cites this paper
• Reappraisal of Ischemic Heart Disease: Fundamental Role of Coronary Microvascular Dysfunction in the Pathogenesis of Angina Pectoris

  2018cites this paper
• International standardization of diagnostic criteria for microvascular angina.

  2018cites this paper
• Regional myocardial function abnormalities are associated with macro- and microcirculation dysfunction in the metabolic syndrome: the RESOLVE study

  2018cites this paper
• 25 – Angina in Patients with Evidence of Myocardial Ischemia and No Obstructive Coronary Artery Disease

  2018cites this paper
• 'Primary' Microvascular Angina: Clinical Characteristics, Pathogenesis and Management.

  2018cites this paper
• Microvascular Angina as a Cause of Ischemia: An Update

  2018cites this paper
• Long-term effects of bariatric surgery on peripheral endothelial function and coronary microvascular function.

  2017cites this paper
• [Coronary microvascular dysfunction : Clinical aspects, diagnosis and therapy].

  2016cites this paper
• Integration of Quantitative Positron Emission Tomography Absolute Myocardial Blood Flow Measurements in the Clinical Management of Coronary Artery Disease

  2016cites this paper
• Coronary endothelial dysfunction in non-obstructive coronary artery disease: Risk, pathogenesis, diagnosis and therapy

  2016cites this paper
• Angina Pectoris and Myocardial Ischemia in the Absence of Obstructive Coronary Artery Disease: Role of Diagnostic Tests

  2016cites this paper
• Stress cardiomyopathy: Is it limited to Takotsubo syndrome? Problems of definition.

  2016cites this paper
• Henry Gewirtz and Vasken Dilsizian Flow Measurements in the Clinical Management of Coronary Artery Disease Integration of Quantitative Positron Emission Tomography Absolute Myocardial Blood

  2016cites this paper
• Assessing the immune phenotype of cardiac syndrome x: a prospective study of biomarkers

  2016cites this paper
• Stress Echo in Microvascular Disease

  2015cites this paper
• Evaluation of Microvascular Disease and Clinical Outcomes.

  2015cites this paper
• Poor Tolerance and Limited Effects of Isosorbide-5-Mononitrate in Microvascular Angina

  2015cites this paper
• Current Diagnostic and Therapeutic Strategies in Microvascular Angina

  2015cites this paper
• Myocardial perfusion echocardiography and coronary microvascular dysfunction.

  2015cites this paper
• Koronare mikrovaskuläre Dysfunktion

  2015cites this paper
• Microvascular angina: an update on diagnosis and treatment.

  2015cites this paper
• Angina pectoris and myocardial ischemia in the absence of obstructive coronary artery disease: practical considerations for diagnostic tests.

  2014cites this paper
• The suppression of regucalcin gene expression may lead to hepatocarcinogenesis

  2014cites this paper
• CMD in the Absence of Myocardial Diseases and Obstructive CAD

  2014cites this paper
• Coronary Microvascular Dysfunction Assessed by Intracoronary Acetylcholine Provocation Testing Is a Frequent Cause of Ischemia and Angina in Patients With Exercise‐Induced Electrocardiographic Changes and Unobstructed Coronary Arteries

  2014cites this paper
• No gender difference in the extent of myocardial ischemia in non-ST elevation myocardial infarction

  2014cites this paper
• Methods to investigate coronary microvascular function in clinical practice

  2013cites this paper
• Coronary microvascular dysfunction in women: an overview of diagnostic strategies

  2013cites this paper
• Cardiac Syndrome X and Myocardial Ischemia: Pathogenesis

  2013cites this paper
• Neutrophil-to-lymphocyte ratio, insulin resistance, and endothelial dysfunction in patients with autosomal dominant polycystic kidney disease

  2013cites this paper
• Lack of Effect of Nitrates on Exercise Stress Test Results in Patients with Microvascular Angina

  2013cites this paper
• Coronary microvascular dysfunction after elective percutaneous coronary intervention: correlation with exercise stress test results.

  2013cites this paper
• The patient with chronic ischemic heart disease. Role of ranolazine in the management of stable angina.

  2012cites this paper
• Effect of bariatric surgery on peripheral flow-mediated dilation and coronary microvascular function.

  2012cites this paper
• Rationale and Pitfalls of Noninvasive Coronary Flow Reserve Estimation in Assessment of Microvascular Disease

  2012cites this paper
• Management of microvascular angina

  2012cites this paper
• PET measurement of adenosine stimulated absolute myocardial blood flow for physiological assessment of the coronary circulation

  2012cites this paper
• Insulin resistance and coronary flow velocity reserve in patients with autosomal dominant polycystic kidney disease

  2012cites this paper
• Diagnosis and prognosis of cardiac syndrome X

  2011cites this paper
• Primary Coronary Microvascular Dysfunction: Clinical Presentation, Pathophysiology, and Management

  2010cites this paper
• Contemporary Reviews in Cardiovascular Medicine

  2010cites this paper
• Improvement of Coronary Flow Velocity Reserve with Telmisartan in Patients with Autosomal-Dominant Polycystic Kidney Disease

  2010cites this paper
• Definitions and incidence of cardiac syndrome X: review and analysis of clinical data

  2010cites this paper
• Contemporary Reviews in Cardiovascular Medicine Primary Coronary Microvascular Dysfunction Clinical Presentation , Pathophysiology , and Management

  2010cites this paper
• Rho Kinase-mediated Coronary Arteriolar Constriction to Endothelin-1: Mechanistic Implications for Cardiac Syndrome X

  2010cites this paper
• Detection of Severe Stenosis and Total Occlusion in the Left Anterior Descending Coronary Artery with Transthoracic Doppler Echocardiography in the Emergency Room

  2009cites this paper
• Evaluation of acute and chronic microvascular coronary disease

  2009cites this paper
• Non-invasive imaging of microvascular damage

  2009cites this paper
• Chapter 17 Chronic Ischaemic Heart Disease

  2009cites this paper
• Therapeutic development in cardiac syndrome X: a need to target the underlying pathophysiology.

  2009cites this paper
• Coronary flow velocity reserve and carotid intima media thickness in patients with autosomal dominant polycystic kidney disease: from impaired tubules to impaired carotid and coronary arteries.

  2008cites this paper
• Relation between stress-induced myocardial perfusion defects on cardiovascular magnetic resonance and coronary microvascular dysfunction in patients with cardiac syndrome X.

  2008cites this paper
• Non-invasive assessment of coronary flow and coronary flow reserve by transthoracic Doppler echocardiography: a magic tool for the real world.

  2008cites this paper
• Impaired coronary flow reserve in patients with metabolic syndrome.

  2008cites this paper
• Cardiac adrenergic nerve function and microvascular dysfunction in patients with cardiac syndrome X

  2008cites this paper